Basler Kantonalbank Stock

Certificat

CACBKB

CH1261618453

Real-time Bid/Ask 10:16:42 2024-06-05 EDT
101.47 CHF / 102.29 CHF -0.18% Intraday chart for Basler Kantonalbank
3 months+0.75%
Date Price Change
24-05-29 102.1 -0.13%

Delayed Quote Swiss Exchange

Last update May 29, 2024 at 11:20 am

More quotes

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying SANOFI
Issuer Basler Kantonalbank
CACBKB
ISINCH1261618453
Date issued 2024-02-07
Strike 87.39
Maturity 2025-08-07 (428 Days)
Parity 1 : 1
Emission price 100 CHF
Emission volume N/A
Settlement both
Currency CHF

Technical Indicators

Highest since issue 103.9 CHF
Lowest since issue 100 CHF
Spread 8.2 CHF
Spread %0.80%

Company Profile

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Sector
-
More about the company

Ratings for Sanofi

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Sanofi

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
90.27 EUR
Average target price
108.2 EUR
Spread / Average Target
+19.85%
Consensus
  1. Stock Market
  2. Certificates
  3. CACBKB Certificat